Clinical Trial Update: Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is investigating whether Vitamin B3 can enhance immunotherapy in patients with bladder cancer, with the study currently not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Cancer

Drugs mentioned

• Vitamin B3 (nicotinamide) (nicotinamide)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Bladder (Urothelial, Transitional Cell) Cancer | Phase 1 | Status: NOT_YET_RECRUITING